MedPath

CENTRO DE DIABETES CURITIBA LTDA

🇧🇷Brazil
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (100.0%)

Effect of Anti-diabetic Drugs on Glycemic Variability

Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2016-10-06
Last Posted Date
2020-03-04
Lead Sponsor
Centro de Diabetes Curitiba Ltda
Target Recruit Count
135
Registration Number
NCT02925559
Locations
🇧🇷

Centro de Diabetes Curitiba, Curitiba, Parana, Brazil

Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability

Phase 4
Completed
Conditions
Osteoporosis
Type 2 Diabetes Mellitus
Menopause
Osteopenia
Interventions
First Posted Date
2012-09-06
Last Posted Date
2016-11-04
Lead Sponsor
Centro de Diabetes Curitiba Ltda
Target Recruit Count
56
Registration Number
NCT01679899
Locations
🇧🇷

Centro de Diabetes Curitiba, Curitiba, Parana, Brazil

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.